title: Eltrombopag for chronic immune thrombocytopenia.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tanimoto
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fukunaga
authors.forename: Akiko
authors.initials: A
authors.lastname: Hori
authors.forename: Fumiharu
authors.initials: F
authors.lastname: Yagasaki
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Ono
mesh_terms: D001208:Asia / Q000208:ethnology; D001565:Benzoates / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002908:Chronic Disease; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015337:Multicenter Studies as Topic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000208:ethnology; D011720:Pyrazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016032:Randomized Controlled Trials as Topic; D053628:Receptors, Thrombopoietin / Q000819:agonists*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; C520809:eltrombopag